Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist ...

September 28, 2011 (San Diego, California) — A topical formulation of the nonsteroidal anti-inflammatory drug (NSAID) diclofenac sodium 1% gel (Voltaren Gel, Endo Pharmaceuticals) shows safety and ...

HONOLULU, HI—Minimal systemic distribution of topical diclofenac sodium gel resulted in a lower incidence of major or moderate drug-drug interactions associated with oral diclofenac and reduced the ...

The FDA has approved Voltaren Arthritis Pain for nonprescription, over-the-counter use, according to a press release. Voltaren (diclofenac sodium topical gel 1%, GlaxoSmithKline), a NSAID previously ...

(RTTNews) - Dr. Reddy's Laboratories Ltd. (DRREDDY, RDY), on Wednesday, announced the launch of over-the-counter or OTC Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren Arthritis ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...

Novartis Corporation Voltaren Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis PARSIPPANY, N.J., Oct. 22 -- Voltaren(R) ...

FDA-Approved Product Is the First Prescription NSAID (Nonsteroidal Anti-Inflammatory Drug) That Patients Can Apply Directly to the Skin at the Site of Pain Associated With Osteoarthritis; Voltaren Gel ...

First US approval for a prescription NSAID (non-steroidal anti-inflammatory drug) treatment that can be applied directly to site of osteoarthritis pain Voltaren Gel is the only prescription topical ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal’ or the “Company”) and PL Developments (PLD) today announced that they have commenced shipments of store brand ...